// App-Quantinova.ai

PB2434 : ETNA VTE Europe: A Contemporary Snapshot of VTE Patients Treated with Edoxaban in Clinical Practice across Eight European Countries

Researchers

Presenter

  • A.T. Cohen

Principal Investigators

  • U. Hoffmann

  • P. Hainaut

  • S. Gaine

  • C. Ay

  • M. Coppens

  • M. Schindewolf

  • D. Jimenez

  • B. Brggenjrgen

  • P. Levy

  • P. Bramlage

  • G. Agnelli

Medical Centers

  • Kings College, Guy`s and St Thomas`NHS Trust, London, United Kingdom

  • University Hospital, Ludwig-Maximilians-University Munich, Division of Angiology, Medical Clinic IV, Munich, Germany

  • Cliniques Universitaires Saint Luc, UCL, Internal Medicine, Brussels, Belgium

  • Mater Misericordiae University Hospital, National Pulmonary Hypertension Unit, Dublin, Ireland

  • Medical University of Vienna, Division of Hematology and Hemostasis, Department of Medicine 1, Vienna, Austria

  • University of Amsterdam, Department of Vascular Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands

  • University Hospital Bern, Swiss Cardiovascular Center, Division of Vascular Medicine, Bern, Switzerland

  • Ramón y Cajal Hospital, Respiratory Department, Madrid, Spain

  • Steinbeis-University, Institute for Health Economics, Berlin, Germany

  • Université Paris-Dauphine, PSL University, LEDa-LEGOS, Paris, France

  • Institute for Pharmacology and Preventive Medicine, Mahlow, Germany

  • University of Perugia, Internal and Cardiovascular Medicine – Stroke Unit, Perugia, Italy

Locations

  • United Kingdom

  • Germany

  • Belgium

  • Ireland

  • Austria

  • Netherlands

  • Switzerland

  • Spain

  • France

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Edoxaban

Outcome

  • N/A

Study Design

  • Non Interventional

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved